Pyramid Biological Corp.

Pyramid Biological Corp. — FDA 510(k) Submissions

Pyramid Biological Corp. has submitted 12 FDA 510(k) premarket notifications since 1993, of which 12 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Single (specified) Analyte Controls (assayed And Unassayed), Antiserum, Cf, Cytomegalovirus, Antisera, Cf, Rubella, Enzyme Linked Immunoabsorption Assay, Treponema Pallidum, Antigens, Iha, Toxoplasma Gondii . Use the specialty filter in the sidebar to narrow results.